West Pharmaceutical Services Inc. (WST) News
Filter WST News Items
WST News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
WST News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest WST News From Around the Web
Below are the latest news stories about WEST PHARMACEUTICAL SERVICES INC that investors may wish to consider to help them evaluate WST as an investment opportunity.
West Pharmaceutical Services to Present at the CJS 25th Annual "New Ideas for the New Year" Investor ConferenceWest Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that Cindy Reiss-Clark, Sr. VP and Chief Commercial Officer; Chad Winters, VP of Finance and Chief Accounting Officer; and John Sweeney, VP of Investor Relations, will present at the CJS 25th Annual "New Ideas for the New Year" Virtual Investor Conference on January 14, 2025 at 10:15 a.m. ET. |
LH vs. WST: Which Stock Is the Better Value Option?LH vs. WST: Which Stock Is the Better Value Option? |
Is It Too Late To Consider Buying West Pharmaceutical Services, Inc. (NYSE:WST)?Let's talk about the popular West Pharmaceutical Services, Inc. ( NYSE:WST ). The company's shares saw a decent share... |
Reasons to Hold West Pharmaceutical Stock in Your Portfolio NowWST continues to gain momentum due to its strength in the Pharma market unit. However, the decline across its Generics and Biologics business units is concerning. |
West Pharmaceutical initiated with a Peer Perform at Wolfe ResearchWolfe Research analyst Doug Schenkel initiated coverage of West Pharmaceutical (WST) with a Peer Perform rating and no price target West Pharm is “perhaps the best-in-class” drug packaging and delivery company in the world, the analyst tells investors in a research note. The firm says that while management is highly regarded and has an extensive track record of strong operating discipline. Street estimates do not look conservative and even relative to those estimates, the shares are currently tr |
West Pharmaceutical upgraded to Buy from Neutral at UBSUBS upgraded West Pharmaceutical (WST) to Buy from Neutral with a price target of $390, up from $350. The firm has incremental confidence in a positive mix shift driven by Annex 1 regulations, wearable injectors, and GLP-1 tailwinds, and tells investors in a research that coupled with a view that destocking headwinds should dissipate soon, the combination drives confidence West can return to long- range plan growth earlier than expected, driving stock performance. Published first on TheFly – the |
West Elects New Director to the BoardWest Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's Board of Directors has elected Janet Haugen as its newest member. With the addition of Ms. Haugen, West's Board has 12 directors. |
Should You Sell Your Holdings in West Pharmaceutical Services (WST)?ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Growth Strategy” third quarter 2024 investor letter. A copy of the letter can be downloaded here. Beginning in July, a significant shift away from large caps fueled a rebound that propelled the Russell Midcap Index 9.21% higher outperforming the large cap Russell 1000 Index’s […] |
MMSI or WST: Which Is the Better Value Stock Right Now?MMSI vs. WST: Which Stock Is the Better Value Option? |
Why Is West Pharmaceutical Services, Inc. (WST) Among the Worst Performing Healthcare Stocks in 2024?We recently compiled a list of the 10 Worst Performing Healthcare Stocks in 2024. In this article, we are going to take a look at where West Pharmaceutical Services, Inc. (NYSE:WST) stands against the other healthcare stocks. The Evolving Landscape of Global Healthcare Spending and Innovation The healthcare industry remains a vital and resilient sector which […] |